retatrutide approval status 2025 fda ema TRIUMPH-4: Beat Every Prediction (Full Data) Retatrutide Timeline: Week-by-Week Results (48
Description
According to one study, patients who took orfoglipron had 12% average weight loss at its highest dose over 72 weeks

We're living in a food carnival," he says

Clinical Trial Data Show Reduced Drug Response To understand how GLP-1 resistance affects treatment outcomes, the team analyzed data from several clinical trials involving people with diabetes

Wang L et al

But if you consistently exercise at the same time you inject, be aware that the absorption spike may be faster than expected

For context, in other studies with different study designs and subject-level differences, researchers have documented weight reductions of up to ~5% with other drugs, e.g., 72% with 2 mg semaglutide after treatment periods of up to 68 weeks
